Loading…
Medical Supplies for Pandemics Act of 2021
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,357 other S bills in the 117th — cohort avg 38d
Medical Supplies for Pandemics Act of 2021 This bill requires the Department of Health and Human Services (HHS) to take specified actions, as part of its management of the Strategic National Stockpile, to establish and maintain domestic reserves of critical medical supplies. Specifically, HHS must (1) create incentives for domestic manufacturers of medical supplies to increase emergency stocks and diversify geographic production; (2) purchase, lease, or enter into joint ventures with respect to facilities and equipment to produce medical supplies; and (3) work with distributors to refresh and replenish medical supplies. HHS must also submit a report to Congress concerning the details of any purchase, lease, or joint venture. The department's authority under the bill to make purchases, leases, or joint ventures for medical supplies terminates on September 30, 2024.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (18)
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2022 · fourth_quarter · Health Issues
Issues related to the distribution of health care products; issues related to pandemic preparedness, including Medical Supplies for Pandemics Act (S. 1693 and H.R. 3463), PREVENT Pandemics Act, (S. 3799); issues related to supply chain security and transportation of medical supplies, including United States Innovation and Competition Act of 2021 (S. 1260); issues related to the expedition of critical medical supplies at US ports.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
PPE supply chain and COVID-19; Strategic National Stockpile; PPE Manufacturing; Support for domestic sourcing of medical/surgical Personal Protective Equipment ("PPE"); United States Innovation and Competition Act of 2021 (S. 1260); Make PPE in America Act (H.R. 2720, S. 1306);Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S.1974). S. 3799, PREVENT Pandemics Act; USICA - COMPETES Act Conference Agreement; Medicare CY23 IPPS proposed rule provision on domestic N95 respirators.
Client expense: Not reported · Firm income: $110,000
2022 · fourth_quarter · Health Issues
PREVENT Pandemics Act (S3799) United States Innovation and Competition Act (S1260) America COMPETES Act of 2022 (HR4521) Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S4348) General Issues related to drug shortages (HR2870) General Issues related to strategic national stockpile (HR3635, S1693, S1974) General Issues related to COVID-19 General Issues related to drug cost oversight General Issues related to domestic manufacturing of pharmaceutical products General issues related to the Public Health Services Act Protecting America from Seasonal and Pandemic Influenza Act (HR9476)
Client expense: $554,860 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Health Issues
Drug Pricing Reform Domestic Manufacturing Medicare implications on biosimilars Appropriations pertaining to FDA inspections and American Made preferences HHS Supply Chain Readiness HHS Biosimilar Uptake American-Made, Security of the American Pharmaceutical and Medical Supply Chain H.R. 2815 - The BIOSIM Act, ASP+8 H.R. 2869 / S. 1427 - Increasing Access to Biosimilars Act of 2021 S. 2082 - Manufacturing API, Drugs, and Excipients (MADE) in America Act S. 1176 - Onshoring Essential Antibiotics Act S. 1693 - Medical Supplies for Pandemics Act 340B Drug Pricing Program HR 3683 Securing America's Pharmaceutical Supply Chain S 2640 Disease X Act S. 2662 Industrial Finance Corporation Act H.R. 7400 /S. 3991 American Made Pharmaceuticals Act Biosimilar Patient and Provider Education (including Part D) FDA foreign inspections S. 3799 PREVENT Pandemics Act ASPR/BARDA funding and policy H.R. 2870 Essential Medicine Strategic Stockpile Act (EMSSA) H.R. 5376 Inflation Reduction Act
Client expense: $275,000 · Firm income: Not reported
2022 · fourth_quarter · Health Issues
Allergy policies (S. 701/H.R. 4114); Diagnostic test reimbursement & regulatory policies (S. 2209/H.R. 4128, S. 2076/H.R. 3932, S.4449/H.R.8188, CY23 CLFS); Precision Medicine (H.R. 6000/H.R. 5989); COVID preparedness products and services; Healthcare supply chain (S. 1693/H.R. 3463, P.L. 117-328); Future pandemic preparedness & response (S. 3799, H.R. 7152/S. 3534, H.R. 3635/S. 1974, P.L. 117-328); User Fees Reauthorization (S. 4328/H.R. 7667); ARPA-H (S. 3819/H.R. 5585); Biotechnology and biomanufacturing.
Client expense: $450,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, White House Office
2022 · third_quarter · Health Issues
Allergy policies (S. 701/H.R. 4114); Diagnostic test reimbursement and regulatory policies (S. 2209/H.R. 4128, S. 2076/H.R. 3932); Precision Medicine H.R. 6000/H.R. 5989); COVID-19 preparedness products and services; Healthcare supply chain (S. 1693/H.R. 3463); Future pandemic preparedness and response (S. 3799, H.R. 7152/S.3534, H.R. 3635/S. 1974); Cancer Moonshot 2.0; Health Equity; User Fees Reauthorization (S. 4328/H.R. 7667); and ARPA-H (S. 3819/H.R. 5585).
Client expense: $870,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2022 · third_quarter · Health Issues
PPE supply chain and COVID-19; Strategic National Stockpile; PPE Manufacturing; Support for domestic sourcing of medical/surgical Personal Protective Equipment ("PPE"); United States Innovation and Competition Act of 2021 (S. 1260); Make PPE in America Act (H.R. 2720, S. 1306);Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S.1974). S. 3799, PREVENT Pandemics Act; USICA - COMPETES Act Conference Agreement; Medicare CY23 IPPS proposed rule provision on domestic N95 respirators.
Client expense: Not reported · Firm income: $110,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2022 · third_quarter · Health Issues
Issues related to the Strategic National Stockpile and pandemic preparedness. H.R.3635/S.1974 - Strengthening America's Strategic National Stockpile Act of 2021. H.R.3463/S.1693 - Medical Supplies for Pandemics Act of 2021. Issues related to supply chain for personal protective equipment (PPE). Issues related to personal protective equipment (PPE) and pandemic preparedness. S.3799 - PREVENT Pandemics Act.
Client expense: Not reported · Firm income: $110,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
Issues relating to COVID diagnostic testing; H.R. 747/S.1018-Access to TESTs Act; H.R. 3463/S. 1693-Medical Supplies for Pandemics Act of 2021; S.1974-Strengthening America's Strategic National Stockpile Act of 2021; S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, H.R. 7667, the "Food and Drug Amendments of 2022"; H.R. 4128/S. 2209; S. 4348 Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022; The Verifying Accurate Leading-edge IVCT Development Act of 2021; Issues related to public health emergency preparedness.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
PREVENT Pandemics Act (S3799) United States Innovation and Competition Act (S1260) America COMPETES Act of 2022 (HR4521) Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S4348) General Issues related to drug shortages (HR2870) General Issues related to strategic national stockpile (HR3635, S1693, S1974) General Issues related to COVID-19 General Issues related to drug cost oversight General Issues related to domestic manufacturing of pharmaceutical products General issues related to the Public Health Services Act
Client expense: $468,291 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · third_quarter · Health Issues
Build Back Better Act Drug Pricing Reform ASP+8 for biosimilars Domestic Manufacturing Medicare implications on biosimilars Appropriations pertaining to FDA inspections and American Made preferences HHS Supply Chain Readiness HHS Biosimilar Uptake American-Made, Security of the American Pharmaceutical and Medical Supply Chain H.R. 2815 - The BIOSIM Act H.R. 2869 / S. 1427 - Increasing Access to Biosimilars Act of 2021 H.R. 2855 - Star Rating for Biosimilars S. 2082 - Manufacturing API, Drugs, and Excipients (MADE) in America Act S. 1176 - Onshoring Essential Antibiotics Act S. 1693 - Medical Supplies for Pandemics Act 340B Drug Pricing Program HR 3683 Securing America's Pharmaceutical Supply Chain S 2640 Disease X Act S. 2662 Industrial Finance Corporation Act H.R. 7400 /S. 3991 American Made Pharmaceuticals Act Biosimilar Patient and Provider Education (including Part D) FDA foreign inspections S. 3799 PREVENT Pandemics Act ASPR/BARDA funding and policy H.R. 2870 Essential Medicine Strategic Stockpile Act (EMSSA) H.R. 5376 Inflation Reduction Act
Client expense: $250,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, White House Office
2022 · third_quarter · Health Issues
Issues related to the distribution of health care products; issues related to pandemic preparedness, including Medical Supplies for Pandemics Act (S. 1693 and H.R. 3463), PREVENT Pandemics Act, (S. 3799); issues related to supply chain security and transportation of medical supplies, including United States Innovation and Competition Act of 2021 (S. 1260); issues related to the expedition of critical medical supplies at US ports.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
Issues related to the Strategic National Stockpile and pandemic preparedness. H.R.3635/S.1974 - Strengthening America's Strategic National Stockpile Act of 2021. H.R.3463/S.1693 - Medical Supplies for Pandemics Act of 2021. Issues related to supply chain for personal protective equipment (PPE). Issues related to personal protective equipment (PPE) and pandemic preparedness. S.3799 - PREVENT Pandemics Act.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2022 · second_quarter · Health Issues
PREVENT Pandemics Act (S3799) United States Innovation and Competition Act (S1260) America COMPETES Act of 2022 (HR4521) Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S4348) General Issues related to drug shortages (HR2870) General Issues related to strategic national stockpile (HR3635, S1693, S1974) General Issues related to COVID-19 General Issues related to drug cost oversight General Issues related to domestic manufacturing of pharmaceutical products General issues related to the Public Health Services Act
Client expense: $287,127 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
Issues related to the distribution of health care products; issues related to pandemic preparedness, including Medical Supplies for Pandemics Act (S. 1693 and H.R. 3463), PREVENT Pandemics Act, S. 3799; issues related to supply chain security and transportation of medical supplies, including United States Innovation and Competition Act of 2021 (S. 1260); issues related to the expedition of critical medical supplies at US ports.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
PPE supply chain and COVID-19; Strategic National Stockpile; PPE Manufacturing; Support for domestic sourcing of medical/surgical Personal Protective Equipment ("PPE"); United States Innovation and Competition Act of 2021 (S. 1260); Make PPE in America Act (H.R. 2720, S. 1306);Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S.1974). S. 3799, PREVENT Pandemics Act; USICA - COMPETES Act Conference Agreement; Medicare CY23 IPPS proposed rule provision on domestic N95 respirators.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2022 · second_quarter · Health Issues
Allergy policies (S. 701/H.R. 4114); Diagnostic test reimbursement and regulatory policies (S. 2209/H.R. 4128, S. 2076/H.R. 3932); Precision Medicine H.R. 6000/H.R. 5989); COVID-19 preparedness products and services; Healthcare supply chain (S. 1693/H.R. 3463); Future pandemic preparedness and response (S. 3799, H.R. 7152/S.3534, H.R. 3635/S. 1974); Cancer Moonshot 2.0; Health Equity; User Fees Reauthorization (S. 4328/H.R. 7667); and ARPA-H (S. 3819/H.R. 5585).
Client expense: $580,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2022 · second_quarter · Health Issues
Issues relating to COVID diagnostic testing; H.R. 747/S.1018-Access to TESTs Act; H.R. 3463/S. 1693-Medical Supplies for Pandemics Act of 2021; S.1974-Strengthening America's Strategic National Stockpile Act of 2021; S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, H.R. 7667, the "Food and Drug Amendments of 2022".
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974); Infrastructure Investment and Jobs Act (Public Law No: 117-58), which includes Make PPE in America Act (H.R. 2720, S. 1306); PREVENT Pandemics Act (S. 3799); America COMPETES Act of 2022 (H.R. 4521); United States Innovation and Competition Act of 2021 (S. 1260)
Client expense: $200,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
Build Back Better Act Drug Pricing Reform ASP+8 for biosimilars Domestic Manufacturing Medicare implications on biosimilars Appropriations pertaining to FDA inspections HHS Supply Chain Readiness HHS Biosimilar Uptake American-Made, Security of the American Pharmaceutical and Medical Supply Chain H.R. 2815 - The BIOSIM Act H.R. 2869 / S. 1427 - Increasing Access to Biosimilars Act of 2021 H.R. 2855 - Star Rating for Biosimilars S. 2082 - Manufacturing API, Drugs, and Excipients (MADE) in America Act S. 1176 - Onshoring Essential Antibiotics Act S. 1693 - Medical Supplies for Pandemics Act 340B Drug Pricing Program HR 3683 Securing America's Pharmaceutical Supply Chain S 2640 Disease X Act S. 2662 Industrial Finance Corporation Act American Made Pharmaceutical Act
Client expense: $250,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, White House Office
2022 · second_quarter · Health Issues
Issues related to H.R. 8592, the EMS Counts Act of 2020. Issues related to the implementation of H.R. 1319, the American Rescue Plan Act of 2021. Issues related to H.R. 1609 / S.149, the Treatment in Place Act. Issues related to H.R. 3463 / S. 1693, the Medical Supplies for Pandemics Act of 2021. Issues related to H.R. 3635 / S. 1974, the Strengthening America's Strategic National Stockpile Act of 2021. Issues related to S. 3910, the EMS Staffing and Support Act. Issues related to S. 2037, the Protecting Access to Ground Ambulance Medical Services Act of 2021. Issues related to H.R. 7850 / S. 4269, the Prevent BLEEDing Act of 2022. Issues related to EMS funding.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
Healthcare supply chain, resiliency and product continuity; The Medical Supplies for Pandemics Act (H.R. 3463/S.1693) concerning medical product supply chain preparedness; The Strengthening Americas Strategic National Stockpile Act (H.R. 3635/S.1974) concerning medical product supply chain preparedness; Prepare for and Respond to Existing Viruses, Emerging New Threats and Pandemics Act (S.3799) concerning medical product supply chain preparedness.
Client expense: $270,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · first_quarter · Health Issues
Issues related to the distribution of health care products; issues related to pandemic preparedness, including Medical Supplies for Pandemics Act (S. 1693 and H.R. 3463), PREVENT Pandemics Act, S. 3799; issues related to supply chain security and transportation of medical supplies, including United States Innovation and Competition Act of 2021 (S. 1260).
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
Legislative and administrative monitoring and outreach on healthcare policy. Legislative and administrative monitoring and outreach on prescription drug pricing/PBMs. Legislative and administrative monitoring and outreach on policy issues affecting Medicaid programs. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. H.R. 2297, MIND Act. S. 150, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021. H.R. 955, Medicaid Reentry Act of 2021. H.R. 379, Improving Social Determinants of Health Act of 2021. H.R. 2903, CONNECT for Health Act of 2021. S. 1512 CONNECT for Health Act of 2021. S. 151, COVID HCBS Relief Act of 2021. H.R. 525, COVID HCBS Relief Act of 2021. H.R. 3203, To enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes. S. 1388, Prescription Pricing for the People Act of 2021. S. 773, A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes. S. 1693, Medical Supplies for Pandemics Act of 2021. H.R. 3463, Medical Supplies for Pandemics Act of 2021. H.R. 5376, Build Back Better Act. H.R. 2471, Consolidated Appropriations Act, 2022 (P.L. 117-103). H.R. 4521, America COMPETES Act of 2022. S. 3799, PREVENT Pandemics Act. H.R. 6963, Accelerated Approval Integrity Act of 2022. H.R. 6996, Accelerating Access for Patients Act of 2022. H.R, 7007, COVID Supplemental Appropriations Act, 2022. H.R. 6833, Affordable Insulin Now Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
Issues related to the Strategic National Stockpile and pandemic preparedness. H.R.3635/S.1974 - Strengthening America's Strategic National Stockpile Act of 2021. H.R.3463/S.1693 - Medical Supplies for Pandemics Act of 2021. Issues related to supply chain for personal protective equipment (PPE). Issues related to personal protective equipment (PPE) and pandemic preparedness. S.3799 - PREVENT Pandemics Act.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2022 · first_quarter · Health Issues
PPE supply chain and COVID-19; Strategic National Stockpile; PPE Manufacturing; Support for domestic sourcing of medical/surgical Personal Protective Equipment ("PPE"); United States Innovation and Competition Act of 2021 (S. 1260); Make PPE in America Act (H.R. 2720, S. 1306); Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974). S. 3799, PREVENT Pandemics Act.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2022 · first_quarter · Health Issues
PREVENT Pandemics Act (S3799) United States Innovation and Competition Act (S1260) America COMPETES Act of 2022 (HR4521) General Issues related to drug shortages (HR2870) General Issues related to strategic national stockpile (HR3635, S1693, S1974) General Issues related to COVID-19 General Issues related to drug cost oversight General Issues related to domestic manufacturing of pharmaceutical products General issues related to the Public Health Services Act
Client expense: $314,575 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
Issues relating to COVID diagnostic testing; H.R. 747/S.1018-Access to TESTs Act; H.R. 3463/S. 1693-Medical Supplies for Pandemics Act of 2021; S.1974-Strengthening America's Strategic National Stockpile Act of 2021.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
Allergy policies (S. 701/H.R. 4114); Diagnostic test reimbursement and regulatory policies (S. 2209/H.R. 4128, S. 2076/H.R. 3932); Precision Medicine (CURES 2.0/H.R. 5989); COVID-19 preparedness products and services; Healthcare supply chain (S. 1693/H.R. 3463); Future pandemic preparedness and response (S. 3799, H.R. 7152/S.3534); Cancer Moonshot 2.0; Health Equity.
Client expense: $740,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2022 · first_quarter · Health Issues
Issues related to H.R. 8592, the EMS Counts Act of 2020. Issues related to the implementation of H.R. 1319, the American Rescue Plan Act of 2021. Issues related to H.R. 1609 / S.149, the Treatment in Place Act. Issues related to H.R. 3463 / S. 1693, the Medical Supplies for Pandemics Act of 2021. Issues related to H.R. 3635 / S. 1974, the Strengthening America's Strategic National Stockpile Act of 2021.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974); Protecting Providers Everywhere (PPE) in America Act (H.R. 1436; S. 308); Infrastructure Investment and Jobs Act (Public Law No: 117-58), which includes Make PPE in America Act (H.R. 2720, S. 1306); Masks for All Act (H.R. 6385); PREVENT Pandemics Act (S. 3799); America COMPETES Act of 2022 (H.R. 4521); United States Innovation and Competition Act of 2021 (S. 1260)
Client expense: $200,000 · Firm income: Not reported
Government targets: Architect of the Capitol (AOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
Build Back Better Act Drug Pricing Reform ASP+8 for biosimilars Domestic Manufacturing Medicare implications on biosimilars Appropriations pertaining to FDA inspections HHS Supply Chain Readiness HHS Biosimilar Uptake American-Made, Security of the American Pharmaceutical and Medical Supply Chain H.R. 2815 - The BIOSIM Act H.R. 2869 / S. 1427 - Increasing Access to Biosimilars Act of 2021 H.R. 2855 - Star Rating for Biosimilars S. 2082 - Manufacturing API, Drugs, and Excipients (MADE) in America Act S. 1176 - Onshoring Essential Antibiotics Act S. 1693 - Medical Supplies for Pandemics Act 340B Drug Pricing Program HR 3683 Securing America's Pharmaceutical Supply Chain S 2640 Disease X Act S. 2662 Industrial Finance Corporation Act American Made Pharmaceutical Act
Client expense: $200,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, White House Office
2021 · fourth_quarter · Health Issues
Issues relating to COVID diagnostic testing; H.R. 747 and S.1018-Access to TESTs Act: H.R. 3463 and S. 1693-Medical Supplies for Pandemics Act of 2021; S.1974-Strengthening America's Strategic National Stockpile Act of 2021.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Health Issues
Build Back Better Act Drug Pricing ASP+8 for biosimilars Domestic Manufacturing Medicare implications on biosimilars Pass Through Status Extension Appropriations and reach out pertaining to FDA inspections HHS Supply Chain Readiness HHS Biosimilar Uptake 340B Drug Pricing Program American-Made, Security of the American Pharmaceutical and Medical Supply Chain H.R. 2815 - The BIOSIM Act H.R. 2869 / S. 1427 - Increasing Access to Biosimilars Act of 2021 H.R. 2855 - Star Rating for Biosimilars S. 2082 - Manufacturing API, Drugs, and Excipients (MADE) in America Act S. 1176 - Onshoring Essential Antibiotics Act S. 1693 - Medical Supplies for Pandemics Act 340B Drug Pricing Program HR 3683 Securing America's Pharmaceutical Supply Chain S 2640 Disease X Act S. 2662 Industrial Finance Corporation Act
Client expense: $160,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Office of Management & Budget (OMB), SENATE, White House Office
2021 · fourth_quarter · Health Issues
Medical supply chain, particularly in response to the COVID-19 pandemic; Endless Frontier Act; HELP Committee bipartisan efforts to improve public health and medical preparedness/response programs; S. 1693/H.R. 3463, Medical Supplies for Pandemics Act of 2021; S. 1974/H.R. 3635, Strengthening Americas Strategic National Stockpile Act of 2021; Healthcare product exclusions from Section 301 tariffs
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2021 · fourth_quarter · Health Issues
PPE supply chain and COVID-19; Strategic National Stockpile; PPE Manufacturing; Support for domestic sourcing of medical/surgical Personal Protective Equipment ("PPE"); United States Innovation and Competition Act of 2021 (S. 1260); Make PPE in America Act (H.R. 2720, S. 1306); Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974)
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2021 · fourth_quarter · Health Issues
General Issues related to drug shortages (HR2870) General Issues related to strategic national stockpile (HR3635, S1693, S1974) General Issues related to COVID-19 General Issues related to drug cost oversight General Issues related to domestic manufacturing of pharmaceutical products General issues related to the Public Health Services Act
Client expense: $303,837 · Firm income: Not reported
Government targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Health Issues
Legislative and administrative monitoring and outreach on healthcare policy. Legislative and administrative monitoring and outreach on prescription drug pricing/PBMs. Legislative and administrative monitoring and outreach on policy issues affecting Medicaid programs. Legislative and administrative monitoring and outreach on the implementation of the Affordable Care Act (ACA) (P.L. 111-148) Legislative outreach related to executive action surrounding the HHS Rebate rule. Legislative outreach and monitoring the implementation of H.R. 259, Medicaid Extenders Act of 2019 (P.L. 116-3). Legislative outreach and monitoring the implementation of H.R. 1319, American Rescue Plan Act of 2021 (P.L. 117-2). Legislative outreach and monitoring the implementation of H.R. 3684, Infrastructure Investment and Jobs Act. (P.L. 117-58). Legislative and administrative monitoring and outreach on activity related to reconciliation and the congressional budget resolution. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. H.R. 2297, MIND Act. S. 439, Coronavirus Medicaid Response Act. H.R. 1353, Coronavirus Medicaid Response Act. S. 150, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021. H.R. 955, Medicaid Reentry Act of 2021. H.R. 379, Improving Social Determinants of Health Act of 2021. H.R. 2903, CONNECT for Health Act of 2021. S. 1512 CONNECT for Health Act of 2021. S. 151, COVID HCBS Relief Act of 2021. H.R. 525, COVID HCBS Relief Act of 2021. H.R. 3203, To enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes. S. 1388, Prescription Pricing for the People Act of 2021. H.R. 928, American Family Act of 2021. S. 773, A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes. S. 1693, Medical Supplies for Pandemics Act of 2021. H.R. 3463, Medical Supplies for Pandemics Act of 2021. H.R. 5376, Build Back Better Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Health Issues
Issues related to the Strategic National Stockpile and pandemic preparedness; Strengthening the Strategic National Stockpile Act (H.R. 3635/S. 1974); Medical Supplies for Pandemics Act (H.R. 3463/S. 1693); Protecting Providers Everywhere (PPE) in America Act (H.R. 1436/S. 308); Issues related to supply chain for personal protective equipment (PPE); Issues related to personal protective equipment (PPE) and pandemic preparedness.
Client expense: Not reported · Firm income: $80,000
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of the Vice President of the United States, SENATE
2021 · fourth_quarter · Health Issues
Issues related to the distribution of health care products; issues related to pandemic preparedness, including Medical Supplies for Pandemics Act, S. 1693 and H.R. 3463; issues related to supply chain security and transportation of medical supplies, including United States Innovation and Competition Act of 2021, S. 1260.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Health Issues
Issues relating to COVID diagnostic testing; H.R. 747 and S.1018-Access to TESTs Act; H.R. 3463 and S. 1693-Medical Supplies for Pandemics Act of 2021; S.1974-Strengthening America's Strategic National Stockpile Act of 2021.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Consumer Issues/Safety/Products
S. 308/H.R. 1436, PPE In America Act S. 936/H.R. 5502, INFORM Consumers Act S. 1260/H.R. 2731, Endless Frontier Act / U.S. Innovation & Competition Act S. 1693/H.R. 3463, Medical Supplies for Pandemics Act Revolving Stockpile for PPE PPE Issues, generally, no specific legislation Efforts to combat counterfeits and price gouging during COVID Implementation of the CARES Act, Public Law 116-136
Client expense: $520,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Commerce, Dept of (DOC), Energy, Dept of, Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Highway Traffic Safety Administration (NHTSA), Patent & Trademark Office (PTO), SENATE, Transportation Security Administration (TSA), Transportation, Dept of (DOT), U.S. Trade Representative (USTR), White House Office
2021 · fourth_quarter · Disaster Planning/Emergencies
S. 308./H.R. 1436, PPE In America Act S. 936/H.R. 5502, INFORM Consumers Act H.R. 3429/H.R. 5374/S.1843, SHOP SAFE Act S. 1260/H.R. 2731, Endless Frontier Act / U.S. Innovation & Competition Act S.1693/H.R. 3463, Medical Supplies for Pandemics Act Revolving Stockpile for PPE / Strategic National Stockpile (SNS) reforms Efforts to combat counterfeits and price gouging during COVID Data collection - PPE supplies and vaccine distribution DOD support for COVID response Efforts to encourage domestic manufacturing of PPE and pandemic response Implementation of the CARES Act, Public Law 116-136
Client expense: $520,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Commerce, Dept of (DOC), Energy, Dept of, Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Highway Traffic Safety Administration (NHTSA), Patent & Trademark Office (PTO), SENATE, Transportation Security Administration (TSA), Transportation, Dept of (DOT), U.S. Trade Representative (USTR), White House Office
2021 · fourth_quarter · Health Issues
Issues related to H.R. 2550, Prevent BLEEDing Act of 2019 and the Stop the Bleed Campaign. Issues related to H.R. 8592, the EMS Counts Act of 2020. Issues related to H.R. 1319, the American Rescue Plan Act of 2021. Issues related to H.R. 1609 and S.149, To amend title XI of the Social Security Act to provide Secretarial authority to temporarily waive or modify application of certain Medicare requirements with respect to ambulance services furnished during certain emergency periods. Issues related to H.R. 3463 / S. 1693, the Medical Supplies for Pandemics Act of 2021. Issues related to H.R. 3635 / S. 1974, the Strengthening America's Strategic National Stockpile Act of 2021.
Client expense: Not reported · Firm income: $30,000
Government targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Natl Highway Traffic Safety Administration (NHTSA), SENATE, Transportation, Dept of (DOT)
2021 · fourth_quarter · Health Issues
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974); Protecting Providers Everywhere (PPE) in America Act (H.R. 1436; S. 308); Infrastructure Investment and Jobs Act (Public Law No: 117-58), which includes Make PPE in America Act (H.R. 2720, S. 1306)
Client expense: $240,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Health Issues
Allergy policies (S. 701/H.R. 4114); Diagnostic test reimbursement and regulatory policies (S. 2209/H.R. 4128, S. 2076/H.R. 3932); Precision Medicine (CURES 2.0/H.R. 5989); COVID-19 preparedness products and services; Vaccine access and distribution; Healthcare supply chain (S. 1693/H.R. 3463); Future pandemic preparedness and response.
Client expense: $330,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE
2021 · third_quarter · Health Issues
Allergy policies (S. 701/H.R. 4114); Diagnostic test reimbursement and regulatory policies (S. 2209/H.R. 4128); Precision Medicine (CURES 2.0); COVID-19 preparedness products and services; Vaccine access and distribution; Healthcare supply chain (S. 1693/H.R. 3463); Future pandemic preparedness and response.
Client expense: $440,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE
2021 · third_quarter · Health Issues
S.164 - Advancing Education on Biosimilars Act of 2021 Pass-Through Status Extension Medicare payments for Biosimilars Appropriations and reach out pertaining to FDA inspections HHS Supply Chain Readiness HHS Biosimilar Uptake 340B Drug Pricing Program American-Made, Security of the American Pharmaceutical and Medical Supply Chain H.R. 2815 - The BIOSIM Act H.R. 2869 / S. 1427 - Increasing Access to Biosimilars Act of 2021 H.R. 2855 - Star Rating for Biosimilars S. 2082 - Manufacturing API, Drugs, and Excipients (MADE) in America Act S. 1176 - Onshoring Essential Antibiotics Act S. 1693 - Medical Supplies for Pandemics Act 340B Drug Pricing Program HR 3683 Securing America's Pharmaceutical Supply Chain S 2640 Disease X Act S. 2662 Industrial Finance Corporation Act
Client expense: $130,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Office of Management & Budget (OMB), SENATE, White House Office
2021 · third_quarter · Health Issues
Medical supply chain, particularly in response to the COVID-19 pandemic; Endless Frontier Act; HELP Committee bipartisan efforts to improve public health and medical preparedness/response programs; Medical Supplies for Pandemics Act of 2021 (S. 1693/H.R. 3463); Strengthening Americas Strategic National Stockpile Act of 2021 (S. 1974/H.R. 3635)
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Health Issues
Legislative and administrative monitoring and outreach on healthcare policy. Legislative and administrative monitoring and outreach on prescription drug pricing/PBMs. Legislative and administrative monitoring and outreach on policy issues affecting Medicaid programs. Legislative and administrative monitoring and outreach on the implementation of the Affordable Care Act (ACA) (P.L. 111-148) Legislative and administrative monitoring and outreach on issues regarding the health insurance tax (HIT). Legislative outreach related to executive action surrounding the HHS Rebate rule. S. 4775, Delivering Immediate Relief to America's Families, Schools and Small Businesses Act. Legislative outreach and monitoring the implementation of H.R. 259, Medicaid Extenders Act of 2019 (P.L. 116-3). Legislative outreach and monitoring the implementation of H.R. 1319, American Rescue Plan Act of 2021 (117-2). Legislative and administrative monitoring and outreach on activity related to reconciliation and the congressional budget resolution. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. H.R. 2297, MIND Act. S. 439, Coronavirus Medicaid Response Act. H.R. 1353, Coronavirus Medicaid Response Act. S. 150, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021. H.R. 955, Medicaid Reentry Act of 2021. H.R. 379, Improving Social Determinants of Health Act of 2021. H.R. 2903, CONNECT for Health Act of 2021. S. 1512 CONNECT for Health Act of 2021. H.R. 3684, Infrastructure Investment and Jobs Act. H.R. 4161 To amend title XIX of the Social Security Act to expand access to home and community-based services (HCBS) under Medicaid, and for other purposes. S. 151, COVID HCBS Relief Act of 2021. H.R. 525, COVID HCBS Relief Act of 2021. H.R. 3203, To enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes. S. 1388, Prescription Pricing for the People Act of 2021. H.R. 928, American Family Act of 2021. S. 773, A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes. S. 1693, Medical Supplies for Pandemics Act of 2021. H.R. 3463, Medical Supplies for Pandemics Act of 2021. H.R. 5376, Build Back Better Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE